Concord Medical Services (NYSE:CCM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCMFree Report) in a research report released on Saturday. The brokerage issued a sell rating on the stock.

Concord Medical Services Stock Performance

NYSE:CCM opened at $5.70 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.32 and a debt-to-equity ratio of 1.14. The business’s 50-day moving average price is $6.91 and its two-hundred day moving average price is $6.69. Concord Medical Services has a twelve month low of $3.82 and a twelve month high of $26.70.

Concord Medical Services Company Profile

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Read More

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.